AbCellera Biologics Inc. ABCL Shares issued and restricted stock units (“RSUs”) vested under stock option plan
Shares issued and restricted stock units (“RSUs”) vested under stock option plan at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept abcl:StockIssuedAndRestrictedStockUnitsVestedDuringPeriodValueStockOptionsExercised.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s shares issued and restricted stock units (“rsus”) vested under stock option plan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s shares issued and restricted stock units (“rsus”) vested under stock option plan?
- AbCellera Biologics Inc. (ABCL) reported shares issued and restricted stock units (“rsus”) vested under stock option plan of $516K in Q1 2026.
- How has AbCellera Biologics Inc.'s shares issued and restricted stock units (“rsus”) vested under stock option plan changed year-over-year?
- AbCellera Biologics Inc.'s shares issued and restricted stock units (“rsus”) vested under stock option plan increased by 241.7% year-over-year, from $151K to $516K.
- What is the long-term trend for AbCellera Biologics Inc.'s shares issued and restricted stock units (“rsus”) vested under stock option plan?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s shares issued and restricted stock units (“rsus”) vested under stock option plan has grown at a -28.7% compound annual growth rate (CAGR), from $1.58M to $806K.
- What does shares issued and restricted stock units (“rsus”) vested under stock option plan mean?
- This tracks the volume of equity instruments issued to employees and service providers upon the vesting of stock-based compensation awards. It serves as a key indicator of potential shareholder dilution and the company's strategy for talent retention and incentive alignment. Tracking this helps investors model the impact of equity-based compensation on the total share count.